European Court of Justice decision on patents on Embryonic stem cell research
Expert reaction to European Court of Justice decision on patents on Embryonic stem cell research.
"A process which involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented. The use of human embryos for therapeutic or diagnostic purposes which are applied to the human embryo and are useful to it is patentable, but their use for purposes of scientific research is not patentable."
For further information see:
or contact the Science Media Centre